Prilosec OTC Shortages Due To Inaccurate Projections, Global Supply Chain
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble is building up enough Prilosec OTC inventory to allow retailers to re-launch the product
You may also be interested in...
Prilosec OTC, Nexium Launches Fed “Shark Fin” Monopoly Plan, Suit Claims
Elements of the Prilosec OTC launch, ranging from the drug's 14-day term of use to supply shortages during its time on the market, were part of a plan by AstraZeneca to interfere with generic competition for its prescription proton pump inhibitors, retailers allege in a lawsuit against the U.K. drug maker
Prilosec OTC, Nexium Launches Fed “Shark Fin” Monopoly Plan, Suit Claims
Elements of the Prilosec OTC launch, ranging from the drug's 14-day term of use to supply shortages during its time on the market, were part of a plan by AstraZeneca to interfere with generic competition for its prescription proton pump inhibitors, retailers allege in a lawsuit against the U.K. drug maker
Prilosec OTC, Nexium Launches Fed “Shark Fin” Monopoly Plan, Suit Claims
Elements of the Prilosec OTC launch, ranging from the drug's 14-day term of use to supply shortages during its time on the market, were part of a plan by AstraZeneca to interfere with generic competition for its prescription proton pump inhibitors, retailers allege in a lawsuit against the U.K. drug maker